Literature DB >> 1396757

Changes in the susceptibility of Bacteroides fragilis group organisms to various antimicrobial agents 1979-1989.

C Betriu1, C Cabronero, M Gomez, J J Picazo.   

Abstract

The in vitro activity of metronidazole, chloramphenicol, clindamycin and 11 beta-lactam antibiotics against 135 clinical isolates of the Bacteroides fragilis group was compared. In addition, changes in the resistance patterns of members of the Bacteroides fragilis group isolated at the Hospital Universitario San Carlos in Madrid, Spain, between 1979 and 1989 were documented. The most active beta-lactam drugs were imipenem and beta-lactamase inhibitor combinations. In 1989, however, two strains were found to be resistant to imipenem and to all other beta-lactam agents tested. There was no emergence of resistance to metronidazole. Chloramphenicol was very effective: only one resistant strain was detected in 1979 and no chloramphenicol-resistant isolates were found during the rest of the study period. An outbreak of clindamycin resistance was noted in 1982, and the first cefoxitin resistant strains were recovered in 1985. The changing patterns of susceptibility of anaerobic bacteria to antimicrobial agents and the emergence of Bacteroides fragilis strains resistant to new beta-lactam agents suggest that periodic antimicrobial susceptibility tests should be performed in order to guide the selection of antimicrobial agents for therapy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1396757     DOI: 10.1007/bf01962077

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  20 in total

1.  Antimicrobial susceptibilities of anaerobic bacteria isolated at the Mayo Clinic during 1982 through 1987: comparison with results from 1977 through 1981.

Authors:  C E Musial; J E Rosenblatt
Journal:  Mayo Clin Proc       Date:  1989-04       Impact factor: 7.616

2.  Survey of Bacteroides fragilis susceptibility patterns in France.

Authors:  J Breuil; C Burnat; O Patey; A Dublanchet
Journal:  J Antimicrob Chemother       Date:  1989-07       Impact factor: 5.790

3.  Bacteroides fragilis resistant to both metronidazole and imipenem.

Authors:  F Lamothe; C Fijalkowski; F Malouin; A M Bourgault; L Delorme
Journal:  J Antimicrob Chemother       Date:  1986-11       Impact factor: 5.790

4.  Susceptibility studies in the Bacteroides fragilis group resistant to clindamycin.

Authors:  J Liñares; J L Pérez; R Martín
Journal:  J Antimicrob Chemother       Date:  1983-09       Impact factor: 5.790

5.  Bacteroides fragilis resistant to metronidazole after long-term therapy.

Authors:  H R Ingham; S Eaton; C W Venables; P C Adams
Journal:  Lancet       Date:  1978-01-28       Impact factor: 79.321

Review 6.  Evolution in antibiotic susceptibility of Bacteroides fragilis group strains in France based on periodic surveys.

Authors:  L Dubreuil; M Derriennic; A Sedallian; C Romond; A L Courtieu
Journal:  Infection       Date:  1989 May-Jun       Impact factor: 3.553

7.  The antibiotic sensitivity of the Bacteroides fragilis group in the United Kingdom.

Authors:  A R Fox; I Phillips
Journal:  J Antimicrob Chemother       Date:  1987-10       Impact factor: 5.790

8.  Emergence of antibiotic resistant strains of Bacteroides fragilis.

Authors:  K S Scher
Journal:  Surg Gynecol Obstet       Date:  1988-09

9.  Epidemiology of clindamycin resistance in the Bacteroides fragilis group.

Authors:  M Reig; M G Campello; F Baquero
Journal:  J Antimicrob Chemother       Date:  1984-12       Impact factor: 5.790

10.  Evolution of antimicrobial susceptibility in isolates of the Bacteroides fragilis group in Spain.

Authors:  J E García-Rodríguez; J E García-Sánchez
Journal:  Rev Infect Dis       Date:  1990 Jan-Feb
View more
  5 in total

1.  Resistance trends of the Bacteroides fragilis group over a 10-year period, 1997 to 2006, in Madrid, Spain.

Authors:  Carmen Betriu; Esther Culebras; María Gómez; Fátima López; Iciar Rodríguez-Avial; Juan J Picazo
Journal:  Antimicrob Agents Chemother       Date:  2008-05-12       Impact factor: 5.191

Review 2.  Imipenem/cilastatin: an update of its antibacterial activity, pharmacokinetics and therapeutic efficacy in the treatment of serious infections.

Authors:  J A Balfour; H M Bryson; R N Brogden
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

3.  In vitro activities of MK-0826 and 16 other antimicrobials against Bacteroides fragilis group strains.

Authors:  C Betriu; A Sánchez; M L Palau; M Gómez; J J Picazo
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

4.  Activities of new antimicrobial agents (trovafloxacin, moxifloxacin, sanfetrinem, and quinupristin-dalfopristin) against Bacteroides fragilis group: comparison with the activities of 14 other agents.

Authors:  C Betriu; M Gómez; M L Palau; A Sánchez; J J Picazo
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

5.  In vitro activities of tigecycline (GAR-936) against recently isolated clinical bacteria in Spain.

Authors:  Carmen Betriu; Iciar Rodríguez-Avial; Blas Ali Sánchez; María Gómez; Juan Alvarez; Juan J Picazo
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.